This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sigal, R. J. Articles by Marliss, E. B. Search for Related Content PubMed PubMed Citation Articles by Sigal, R. J. Articles by Marliss, E. B.

Glucoregulation during and after Intense Exercise: Effects of ß-Adrenergic Blockade in Subjects with Type 1 Diabetes Mellitus¹

McGill Nutrition and Food Science Center, Royal Victoria Hospital (E.B.M.), Montreal, Quebec, Canada H3A 1A1; the Departments of Physiology and Medicine, University of Toronto (S.J.F., M.V.), Toronto, Ontario, Canada M5S 1A8; the Department of Internal Medicine and Institute of Gerontology, University of Michigan and Veterans Affairs Medical Center (J.B.H.), Ann Arbor, Michigan 48109; and the Department of Medicine and Loeb Health Research Institute, University of Ottawa (R.J.S.), Ottawa, Ontario, Canada K1Y 4E9

Address all correspondence and requests for reprints to: Dr. Errol B. Marliss, McGill Nutrition and Food Science Centre, Royal Victoria Hospital, 687 Pine Avenue West, Montréal, Québec, Canada H3A 1A1. E-mail: emarliss{at}rvhmed.lan.mcgill.ca

In intense exercise (>80% maximum oxygen uptake) a huge, up to 8-fold increase in glucose production (Ra) is tightly correlated to marked increases in plasma norepinephrine (NE) and epinephrine. Both Ra and glucose uptake (Rd) are enhanced, not reduced, during ß-adrenergic blockade in normal subjects. ß-Blockade also caused a greater fall in immunoreactive insulin (IRI) during exercise, which could, in turn, have increased Ra directly or via an increased glucagon/insulin ratio. To control for adrenergic effects on endogenous insulin secretion, we tested type 1 diabetic subjects (DM) made euglycemic by overnight iv insulin that was kept constant in rate during and after exercise. Their responses to postabsorptive cycle ergometer exercise at 85–87% maximum oxygen uptake for approximately 14 min were compared to those of similar male control (CP) subjects. Six DM and seven CP subjects received iv 150 µg/kg propranolol over 20 min, then 80 µg/kg·min from -30 min, during exercise and for 60 min during recovery. Plasma glucose increased from similar resting values to peaks of 6.8 mmol/L in DM and 6.5 mmol/L in CP, then returned to resting values in CP within 20 min, but in DM, remained higher than in CP from 8–60 min (P = 0.049). Ra rose rapidly until exhaustion, to 13.3 mg/kg·min in CP and 11.6 in DM (P = NS). Ra declined rapidly in recovery, although somewhat more slowly in DM (P = 0.013 from 2–15 min). The Rd increased to 10.6 in CP and 9.2 mg/kg·min in DM (P = NS), then declined similarly in early recovery, but remained higher in CP from 50–100 min (P = 0.05). The rises in plasma glucose during exercise in both groups were thus due to the increments in Rd less than those in Ra. The higher recovery glucose in DM was due to the slower decline in Ra and the lower Rd in later recovery. IRI was higher in DM than in CP before exercise (P = 0.011), and whereas it decreased in CP (P < 0.05), it increased approximately 2-fold in DM, thus being higher throughout exercise (P = 0.003). The glucagon/insulin ratio was unchanged in DM, but increased in CP during exercise (P = 0.002). NE showed a rapid, marked increment during exercise to peak values of 23.7 nmol/L in CP and 25.7 nmol/L in DM (P = NS), and epinephrine showed parallel responses. Both correlated significantly with the Ra responses. In summary, the Ra responses of both DM and CP during exercise were greater than those of control unblocked subjects (previously reported) despite higher IRI (all exogenous) in DM. This suggests an important contribution of direct -adrenergic stimulation to this Ra effect.

This article has been cited by other articles:

				V. A. Bussau, L. D. Ferreira, T. W. Jones, and P. A. Fournier The 10-s Maximal Sprint: A novel approach to counter an exercise-mediated fall in glycemia in individuals with type 1 diabetes. Diabetes Care, March 1, 2006; 29(3): 601 - 606. [Abstract] [Full Text] [PDF]

				R. J. Sigal, G. P. Kenny, D. H. Wasserman, and C. Castaneda-Sceppa Physical Activity/Exercise and Type 2 Diabetes Diabetes Care, October 1, 2004; 27(10): 2518 - 2539. [Full Text] [PDF]

				R. P. Hoffman, C. A. Sinkey, J. M. Dopp, and B. G. Phillips Systemic and Local Adrenergic Regulation of Muscle Glucose Utilization During Hypoglycemia in Healthy Subjects Diabetes, March 1, 2002; 51(3): 734 - 742. [Abstract] [Full Text] [PDF]

				E. B. Marliss and M. Vranic Intense Exercise Has Unique Effects on Both Insulin Release and Its Roles in Glucoregulation: Implications for Diabetes Diabetes, February 1, 2002; 51(90001): S271 - 283. [Abstract] [Full Text] [PDF]